share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  04/18 08:21
Moomoo AI 已提取核心訊息
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
2024年4月12日，在納斯達克上市的交易代碼爲ICU的公司海星醫療控股公司宣佈了其公司章程的修訂。董事會批准了第二修正和重述的章程，其中包括重大變更，例如將股東會議的法定人數門檻從多數降低到已發行和流通普通股的至少 33 1/ 3%。此外，修正案從章程中刪除了與 “一致行動” 相關的定義和條款，影響了提名股東的識別方式。這些變更詳見向美國證券交易委員會提交的8-K表格所附的附錄3.1。該公司被認定爲新興成長型公司，已進行了這些修正以簡化其治理流程。經修訂的章程的全文以引用方式納入報告，可供審查。
2024年4月12日，在納斯達克上市的交易代碼爲ICU的公司海星醫療控股公司宣佈了其公司章程的修訂。董事會批准了第二修正和重述的章程，其中包括重大變更，例如將股東會議的法定人數門檻從多數降低到已發行和流通普通股的至少 33 1/ 3%。此外，修正案從章程中刪除了與 “一致行動” 相關的定義和條款，影響了提名股東的識別方式。這些變更詳見向美國證券交易委員會提交的8-K表格所附的附錄3.1。該公司被認定爲新興成長型公司，已進行了這些修正以簡化其治理流程。經修訂的章程的全文以引用方式納入報告，可供審查。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息